{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:54:36Z","timestamp":1791838476156,"version":"4.3.4"},"reference-count":186,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11030-019-09992-x","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T04:39:45Z","timestamp":1568349585000},"page":"1367-1383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Coumarins: antifungal effectiveness and future therapeutic scope"],"prefix":"10.1007","volume":"24","author":[{"given":"Jyoti Sankar","family":"Prusty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8735-479X","authenticated-orcid":false,"given":"Awanish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,13]]},"reference":[{"key":"9992_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejmech.2015.11.027","volume":"108","author":"Q Ji","year":"2016","unstructured":"Ji Q, Ge Z, Ge Z, Chen K, Wu H, Liu X, Huang Y, Yuan L, Yang X, Liao F (2016) Synthesis and biological evaluation of novel phosphoramidate derivatives of coumarin as chitin synthase inhibitors and antifungal agents. Eur J Med Chem 108:166\u2013176. https:\/\/doi.org\/10.1016\/j.ejmech.2015.11.027","journal-title":"Eur J Med Chem"},{"key":"9992_CR2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/10942910701567364","volume":"11","author":"I Gulcin","year":"2008","unstructured":"Gulcin I, Tel AZ, Kirecci E (2008) Antioxidant, antimicrobial, antifungal, and antiradical activities of Cyclotrichium niveum (Boiss.) Manden and Scheng. Int J Food Prop 11:450\u2013471. https:\/\/doi.org\/10.1080\/10942910701567364","journal-title":"Int J Food Prop"},{"key":"9992_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0308-8146(03)00098-0","volume":"83","author":"\u0130 G\u00fcl\u00e7\u0131n","year":"2003","unstructured":"G\u00fcl\u00e7\u0131n \u0130, Oktay M, K\u0131re\u00e7c\u0131 E, K\u00fcfrev\u0131o\u01e7lu \u00d6\u0130 (2003) Screening of antioxidant and antimicrobial activities of anise (Pimpinella anisum L.) seed extracts. Food Chem 83:371\u2013382. https:\/\/doi.org\/10.1016\/S0308-8146(03)00098-0","journal-title":"Food Chem"},{"key":"9992_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jep.2003.09.028","volume":"90","author":"I G\u00fcl\u00e7in","year":"2004","unstructured":"G\u00fcl\u00e7in I, K\u00fcfrevio\u01e7lu \u00d6\u0130, Oktay M, B\u00fcy\u00fckokuro\u01e7lu ME (2004) Antioxidant, antimicrobial, antiulcer and analgesic activities of nettle (Urtica dioica L.). J Ethnopharmacol 90:205\u2013215. https:\/\/doi.org\/10.1016\/j.jep.2003.09.028","journal-title":"J Ethnopharmacol"},{"key":"9992_CR5","doi-asserted-by":"publisher","first-page":"a019273","DOI":"10.1101\/cshperspect.a019273","volume":"5","author":"JR K\u00f6hler","year":"2015","unstructured":"K\u00f6hler JR, Casadevall A, Perfect J (2015) The spectrum of fungi that infects humans. Cold Spring Harb Perspect Med 5:a019273. https:\/\/doi.org\/10.1101\/cshperspect.a019273","journal-title":"Cold Spring Harb Perspect Med"},{"key":"9992_CR6","volume-title":"Pharmacognosy, phytochemistry, medicinal plants","author":"J Bruneton","year":"1995","unstructured":"Bruneton J (1995) Pharmacognosy, phytochemistry, medicinal plants. Lavoisier Publishing, Paris"},{"key":"9992_CR7","first-page":"99","volume":"17","author":"M Iranshahi","year":"2009","unstructured":"Iranshahi M, Askari M, Sahebkar A, Adjipavlou-Litina D (2009) Evaluation of antioxidant, anti-inflammatory and lipoxygenase inhibitory activities of the prenylated coumarin umbelliprenin. Daru J Pharma Sci 17:99\u2013103","journal-title":"Daru J Pharma Sci"},{"key":"9992_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1517\/13543776.2012.678835","volume":"22","author":"C Kontogiorgis","year":"2012","unstructured":"Kontogiorgis C, Detsi A, Hadjipavlou-Litina D (2012) Coumarin-based drugs: a patent review (2008-present). Expert Opin Ther Pat 22:437\u2013454. https:\/\/doi.org\/10.1517\/13543776.2012.678835","journal-title":"Expert Opin Ther Pat"},{"key":"9992_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1006\/faat.1996.0181","volume":"34","author":"BG Lake","year":"1996","unstructured":"Lake BG, Grasso P (1996) Comparison of the hepatotoxicity of coumarin in the rat, mouse, and Syrian hamster: a dose and time response study. Fundam Appl Toxicol 34:105\u2013117. https:\/\/doi.org\/10.1006\/faat.1996.0181","journal-title":"Fundam Appl Toxicol"},{"key":"9992_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/jps.2600530302","volume":"53","author":"TO Soine","year":"1964","unstructured":"Soine TO (1964) Naturally occurring coumarins and related physiological activities. J Pharm Sci 53:231\u2013264. https:\/\/doi.org\/10.1002\/jps.2600530302","journal-title":"J Pharm Sci"},{"key":"9992_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/0929867053507315","volume":"12","author":"F Borges","year":"2005","unstructured":"Borges F, Roleira F, Milhazes N, Santana L, Uriarte E (2005) Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr Med Chem 12:887\u2013916. https:\/\/doi.org\/10.2174\/0929867053507315","journal-title":"Curr Med Chem"},{"key":"9992_CR12","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.2174\/1381612043382710","volume":"10","author":"KC Fylaktakidou","year":"2004","unstructured":"Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN (2004) Natural and synthetic coumarin derivatives with anti-inflammatory\/antioxidant activities. Curr Pharm Des 10:3813\u20133833. https:\/\/doi.org\/10.2174\/1381612043382710","journal-title":"Curr Pharm Des"},{"key":"9992_CR13","doi-asserted-by":"publisher","DOI":"10.3109\/03602539008991449","author":"D Egan","year":"1990","unstructured":"Egan D, O\u2019kennedy R, Moran E, Cox D, Prosser E, Thornes RD (1990) The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev. https:\/\/doi.org\/10.3109\/03602539008991449","journal-title":"Drug Metab Rev"},{"key":"9992_CR14","first-page":"453","volume":"68","author":"A Dini","year":"1992","unstructured":"Dini A, Ramundo E, Saturnino P, Scimone A, Stagno IdA (1992) Isolation, characterization and antimicrobial activity of coumarin derivatives from Cyperus incompletus. Boll Soc Ital Biol Sper 68:453\u2013461","journal-title":"Boll Soc Ital Biol Sper"},{"key":"9992_CR15","doi-asserted-by":"publisher","first-page":"165rv113","DOI":"10.1126\/scitranslmed.3004404","volume":"4","author":"GD Brown","year":"2012","unstructured":"Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC (2012) Hidden killers: human fungal infections. Sci Transl Med 4:165rv113\u2013165rv113. https:\/\/doi.org\/10.1126\/scitranslmed.3004404","journal-title":"Sci Transl Med"},{"key":"9992_CR16","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.1128\/AEM.71.9.5544-5550.2005","volume":"71","author":"HE O\u2019Brien","year":"2005","unstructured":"O\u2019Brien HE, Parrent JL, Jackson JA, Moncalvo J-M, Vilgalys R (2005) Fungal community analysis by large-scale sequencing of environmental samples. Appl Environ Microbiol 71:5544\u20135550. https:\/\/doi.org\/10.1128\/AEM.71.9.5544-5550.2005","journal-title":"Appl Environ Microbiol"},{"key":"9992_CR17","doi-asserted-by":"publisher","first-page":"a019273","DOI":"10.1101\/cshperspect.a019273","volume":"5","author":"J K\u00f6hler","year":"2014","unstructured":"K\u00f6hler J, Casadevall A, Perfect J (2014) The spectrum of fungi that infects humans. Cold Spring Harb Perspect Med 5:a019273. https:\/\/doi.org\/10.1101\/cshperspect.a019273","journal-title":"Cold Spring Harb Perspect Med"},{"key":"9992_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.chom.2007.07.004","volume":"2","author":"JL Reedy","year":"2007","unstructured":"Reedy JL, Bastidas RJ, Heitman J (2007) The virulence of human pathogenic fungi: notes from the south of France. Cell Host Microbe 2:77\u201383. https:\/\/doi.org\/10.1016\/j.chom.2007.07.004","journal-title":"Cell Host Microbe"},{"key":"9992_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1439-0507.2011.02134.x","volume":"54","author":"G Sganga","year":"2011","unstructured":"Sganga G (2011) Fungal infections in immunocompromised patients. Mycoses 54:1. https:\/\/doi.org\/10.1111\/j.1439-0507.2011.02134.x","journal-title":"Mycoses"},{"key":"9992_CR20","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1016\/j.bmc.2012.04.045","volume":"20","author":"MK Kathiravan","year":"2012","unstructured":"Kathiravan MK, Salake AB, Chothe AS, Dudhe PB, Watode RP, Mukta MS, Gadhwe S (2012) The biology and chemistry of antifungal agents: a review. Bioorg Med Chem 20:5678\u20135698. https:\/\/doi.org\/10.1016\/j.bmc.2012.04.045","journal-title":"Bioorg Med Chem"},{"key":"9992_CR21","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrmicro1978","volume":"6","author":"RE Ley","year":"2008","unstructured":"Ley RE, Lozupone CA, Hamady M, Knight R, Gordon JI (2008) Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Microbiol 6:776\u2013788. https:\/\/doi.org\/10.1038\/nrmicro1978","journal-title":"Nat Rev Microbiol"},{"key":"9992_CR22","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1126\/science.1195568","volume":"330","author":"YK Lee","year":"2010","unstructured":"Lee YK, Mazmanian SK (2010) Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330:1768\u20131773. https:\/\/doi.org\/10.1126\/science.1195568","journal-title":"Science"},{"key":"9992_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11046-008-9100-9","volume":"166","author":"C Seebacher","year":"2008","unstructured":"Seebacher C, Bouchara J-P, Mignon B (2008) Updates on the epidemiology of dermatophyte infections. Mycopathologia 166:335\u2013352. https:\/\/doi.org\/10.1007\/s11046-008-9100-9","journal-title":"Mycopathologia"},{"key":"9992_CR24","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1171700","volume":"324","author":"EA Grice","year":"2009","unstructured":"Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, Bouffard GG, Blakesley RW, Murray PR, Green ED (2009) Topographical and temporal diversity of the human skin microbiome. Science 324:1190\u20131192. https:\/\/doi.org\/10.1126\/science.1171700","journal-title":"Science"},{"key":"9992_CR25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/exd.12482","volume":"23","author":"AC Jahns","year":"2014","unstructured":"Jahns AC, Alexeyev OA (2014) Three dimensional distribution of Propionibacterium acnes biofilms in human skin. Exp Dermatol 23:687\u2013689. https:\/\/doi.org\/10.1111\/exd.12482","journal-title":"Exp Dermatol"},{"key":"9992_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","volume":"51","author":"B Havlickova","year":"2008","unstructured":"Havlickova B, Czaika VA, Friedrich M (2008) Epidemiological trends in skin mycoses worldwide. Mycoses 51:2\u201315. https:\/\/doi.org\/10.1111\/j.1439-0507.2008.01606.x","journal-title":"Mycoses"},{"key":"9992_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nrmicro2182","volume":"7","author":"M Otto","year":"2009","unstructured":"Otto M (2009) Staphylococcus epidermidis\u2014the \u2018accidental\u2019 pathogen. Nat Rev Microbiol 7:555\u2013567. https:\/\/doi.org\/10.1038\/nrmicro2182","journal-title":"Nat Rev Microbiol"},{"key":"9992_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.pop.2015.08.001","volume":"42","author":"F Ibrahim","year":"2015","unstructured":"Ibrahim F, Khan T, Pujalte GG (2015) Bacterial skin infections. Prim Care 42:485\u2013499. https:\/\/doi.org\/10.1016\/j.pop.2015.08.001","journal-title":"Prim Care"},{"key":"9992_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature12171","volume":"498","author":"K Findley","year":"2013","unstructured":"Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, Schoenfeld D, Nomicos E, Park M, Sequencing NISCC (2013) Topographic diversity of fungal and bacterial communities in human skin. Nat 498:367\u2013370. https:\/\/doi.org\/10.1038\/nature12171","journal-title":"Nat"},{"key":"9992_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/0974-777x.77288","volume":"3","author":"V Mohandas","year":"2011","unstructured":"Mohandas V, Ballal M (2011) Distribution of Candida species in different clinical samples and their virulence: biofilm formation, proteinase and phospholipase production: a study on hospitalized patients in southern India. J Glob Infect Dis 3:4\u20138. https:\/\/doi.org\/10.4103\/0974-777x.77288","journal-title":"J Glob Infect Dis"},{"key":"9992_CR31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.it.2016.04.007","volume":"37","author":"SW Kashem","year":"2016","unstructured":"Kashem SW, Kaplan DH (2016) Skin immunity to Candida albicans. Trends Immunol 37:440\u2013450. https:\/\/doi.org\/10.1016\/j.it.2016.04.007","journal-title":"Trends Immunol"},{"key":"9992_CR32","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/0002-9394(66)91928-3","volume":"62","author":"H Nema","year":"1966","unstructured":"Nema H, Ahuja O, Bal A, Mohapatra L (1966) Mycotic flora of the conjunctiva. Am J Ophthalmol 62:968\u2013970. https:\/\/doi.org\/10.1016\/0002-9394(66)91928-3","journal-title":"Am J Ophthalmol"},{"key":"9992_CR33","first-page":"126","volume":"60","author":"H Yu","year":"1965","unstructured":"Yu H (1965) Studies on fungi of the normal skin. Hifuka Kiyo 60:126\u2013174","journal-title":"Hifuka Kiyo"},{"key":"9992_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.clindermatol.2005.01.003","volume":"23","author":"I Vennewald","year":"2005","unstructured":"Vennewald I, Wollina U (2005) Cutaneous infections due to opportunistic molds: uncommon presentations. Clin Dermatol 23:565\u2013571. https:\/\/doi.org\/10.1016\/j.clindermatol.2005.01.003","journal-title":"Clin Dermatol"},{"key":"9992_CR35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1542\/peds.78.2.225","volume":"78","author":"JE Baley","year":"1986","unstructured":"Baley JE, Kliegman RM, Boxerbaum B, Fanaroft AA (1986) Fungal colonization in the very low birth weight infant. Pediatrics 78:225\u2013232","journal-title":"Pediatrics"},{"key":"9992_CR36","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/00006454-199809000-00014","volume":"17","author":"YC Huang","year":"1998","unstructured":"Huang YC, Li CC, Lin TY, Lien RI, Chou YH, Wu JL, Hsueh C (1998) Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect Dis J 17:819\u2013822. https:\/\/doi.org\/10.1097\/00006454-199809000-00014","journal-title":"Pediatr Infect Dis J"},{"key":"9992_CR37","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/00006454-199406000-00011","volume":"13","author":"AE El-Mohandes","year":"1994","unstructured":"El-Mohandes AE, Johnson-Robbins L, Keiser JF, Simmens SJ, Aure MV (1994) Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease. Pediatr Infect Dis J 13:520\u2013524. https:\/\/doi.org\/10.1097\/00006454-199406000-00011","journal-title":"Pediatr Infect Dis J"},{"key":"9992_CR38","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1128\/jcm.41.2.735-741.2003","volume":"41","author":"E Roilides","year":"2003","unstructured":"Roilides E, Farmaki E, Evdoridou J, Francesconi A, Kasai M, Filioti J, Tsivitanidou M, Sofianou D, Kremenopoulos G, Walsh TJ (2003) Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol 41:735\u2013741. https:\/\/doi.org\/10.1128\/jcm.41.2.735-741.2003","journal-title":"J Clin Microbiol"},{"key":"9992_CR39","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1126\/science.1222236","volume":"336","author":"GD Brown","year":"2012","unstructured":"Brown GD, Denning DW, Levitz SM (2012) Tackling human fungal infections. Am Assoc Adv Sci 336:647. https:\/\/doi.org\/10.1126\/science.1222236","journal-title":"Am Assoc Adv Sci"},{"key":"9992_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0190-9622(08)81260-1","volume":"31","author":"CH Kirkpatrick","year":"1994","unstructured":"Kirkpatrick CH (1994) Chronic mucocutaneous candidiasis. J Am Acad Dermatol 31:14\u201317. https:\/\/doi.org\/10.1016\/S0190-9622(08)81260-1","journal-title":"J Am Acad Dermatol"},{"key":"9992_CR41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/s0738-081x(99)00136-4","volume":"18","author":"RA Johnson","year":"2000","unstructured":"Johnson RA (2000) HIV disease: mucocutaneous fungal infections in HIV disease. Clin Dermatol 18:411\u2013422. https:\/\/doi.org\/10.1016\/s0738-081x(99)00136-4","journal-title":"Clin Dermatol"},{"key":"9992_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/jof4010022","volume":"4","author":"J Richardson","year":"2018","unstructured":"Richardson J, Ho J, Naglik J (2018) Candida\u2013Epithelial interactions. J Fungi 4:22. https:\/\/doi.org\/10.3390\/jof4010022","journal-title":"J Fungi"},{"key":"9992_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/21505594.2016.1235653","volume":"8","author":"KD Goughenour","year":"2017","unstructured":"Goughenour KD, Rappleye CA (2017) Antifungal therapeutics for dimorphic fungal pathogens. Virulence 8:211\u2013221. https:\/\/doi.org\/10.1080\/21505594.2016.1235653","journal-title":"Virulence"},{"key":"9992_CR44","volume-title":"Human pathogenic fungi: molecular biology and pathogenic mechanisms","author":"DJ Sullivan","year":"2014","unstructured":"Sullivan DJ, Moran GP (2014) Human pathogenic fungi: molecular biology and pathogenic mechanisms. Caister Academic Press, Poole"},{"key":"9992_CR45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0140-6736(94)91287-4","volume":"344","author":"K Supparatpinyo","year":"1994","unstructured":"Supparatpinyo K, Khamwan C, Baosoung V, Sirisanthana T, Nelson K (1994) Disseminated Penicillium marneffei infection in southeast Asia. Lancet 344:110\u2013113. https:\/\/doi.org\/10.1016\/S0140-6736(94)91287-4","journal-title":"Lancet"},{"key":"9992_CR46","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bmc.2009.11.009","volume":"18","author":"FM Garibotto","year":"2010","unstructured":"Garibotto FM, Garro AD, Masman MF, Rodr\u00edguez AM, Luiten PG, Raimondi M, Zacchino SA, Somlai C, Penke B, Enriz RD (2010) New small-size peptides possessing antifungal activity. Bioorg Med Chem 18:158\u2013167. https:\/\/doi.org\/10.1016\/j.bmc.2009.11.009","journal-title":"Bioorg Med Chem"},{"key":"9992_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2334-6-21","volume":"6","author":"M Bassetti","year":"2006","unstructured":"Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C (2006) Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6:21. https:\/\/doi.org\/10.1186\/1471-2334-6-21","journal-title":"BMC Infect Dis"},{"key":"9992_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/B978-1-4160-5680-5.00002-5","volume-title":"Clinical mycology","author":"RA Cramer","year":"2009","unstructured":"Cramer RA, Perfect JR (2009) Recent advances in understanding human opportunistic fungal pethogenesis mechanisms. In: Anaissie EJ, McGinnis MR, Pfaller MA (eds) Clinical mycology, 2nd edn. Churchill Livingstone, Edinburg, pp 15\u201331. https:\/\/doi.org\/10.1016\/B978-1-4160-5680-5.00002-5","edition":"2"},{"key":"9992_CR49","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.fbr.2007.02.007","volume":"21","author":"A Casadevall","year":"2007","unstructured":"Casadevall A (2007) Determinants of virulence in the pathogenic fungi. Fungal Biol Rev 21:130\u2013132. https:\/\/doi.org\/10.1016\/j.fbr.2007.02.007","journal-title":"Fungal Biol Rev"},{"key":"9992_CR50","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0966-842X(01)02094-7","volume":"9","author":"RA Calderone","year":"2001","unstructured":"Calderone RA, Fonzi WA (2001) Virulence factors of Candida albicans. Trends Microbiol 9:327\u2013335. https:\/\/doi.org\/10.1016\/S0966-842X(01)02094-7","journal-title":"Trends Microbiol"},{"key":"9992_CR51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4161\/viru.22913","volume":"4","author":"FL Mayer","year":"2013","unstructured":"Mayer FL, Wilson D, Hube B (2013) Candida albicans pathogenicity mechanisms. Virulence 4:119\u2013128. https:\/\/doi.org\/10.4161\/viru.22913","journal-title":"Virulence"},{"key":"9992_CR52","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.femsim.2005.05.014","volume":"45","author":"MJS Mendes-Giannini","year":"2005","unstructured":"Mendes-Giannini MJS, Soares CP, da Silva JLM, Andreotti PF (2005) Interaction of pathogenic fungi with host cells: molecular and cellular approaches. FEMS Immunol Med Microbiol 45:383\u2013394. https:\/\/doi.org\/10.1016\/j.femsim.2005.05.014","journal-title":"FEMS Immunol Med Microbiol"},{"key":"9992_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-12173-9_2","author":"MSA Khan","year":"2010","unstructured":"Khan MSA, Ahmad I, Aqil F, Owais M, Shahid M, Musarrat J (2010) Virulence and pathogenicity of fungal pathogens with special reference to Candida albicans. Combat Fungal Infect. https:\/\/doi.org\/10.1007\/978-3-642-12173-9_2","journal-title":"Combat Fungal Infect"},{"key":"9992_CR54","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1099\/mic.0.25932-0","volume":"149","author":"X Li","year":"2003","unstructured":"Li X, Yan Z, Xu J (2003) Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 149:353\u2013362. https:\/\/doi.org\/10.1099\/mic.0.25932-0","journal-title":"Microbiology"},{"key":"9992_CR55","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/538694","author":"MA Kabir","year":"2012","unstructured":"Kabir MA, Hussain MA, Ahmad Z (2012) Candida albicans: a model organism for studying fungal pathogens. ISRN Microbiol. https:\/\/doi.org\/10.5402\/2012\/538694","journal-title":"ISRN Microbiol"},{"key":"9992_CR56","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrmicro1960","volume":"6","author":"CA Kumamoto","year":"2008","unstructured":"Kumamoto CA (2008) Molecular mechanisms of mechanosensing and their roles in fungal contact sensing. Nat Rev Microbiol 6:667\u2013673. https:\/\/doi.org\/10.1038\/nrmicro1960","journal-title":"Nat Rev Microbiol"},{"key":"9992_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00294-003-0415-2","volume":"44","author":"D Davis","year":"2003","unstructured":"Davis D (2003) Adaptation to environmental pH in Candida albicans and its relation to pathogenesis. Curr Genet 44:1\u20137. https:\/\/doi.org\/10.1007\/s00294-003-0415-2","journal-title":"Curr Genet"},{"key":"9992_CR58","doi-asserted-by":"publisher","first-page":"e01646-01616","DOI":"10.1128\/mBio.01646-16","volume":"7","author":"HA Danhof","year":"2016","unstructured":"Danhof HA, Vylkova S, Vesely EM, Ford AE, Gonzalez-Garay M, Lorenz MC (2016) Robust extracellular pH modulation by Candida albicans during growth in carboxylic acids. MBio 7:e01646-01616. https:\/\/doi.org\/10.1128\/mBio.01646-16","journal-title":"MBio"},{"key":"9992_CR59","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/mmy.38.s1.113.123","volume":"38","author":"MJS Mendes-Giannini","year":"2000","unstructured":"Mendes-Giannini MJS, Taylor M, Bouchara J, Burger E, Calich V, Escalante E, Hanna S, Lenzi H, Machado M, Miyaji M (2000) Pathogenesis II: fungal responses to host responses: interaction of host cells with fungi. Med Mycol 38:113\u2013123. https:\/\/doi.org\/10.1080\/mmy.38.s1.113.123","journal-title":"Med Mycol"},{"key":"9992_CR60","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1128\/.61.2.136-169.1997","volume":"61","author":"BB Finlay","year":"1997","unstructured":"Finlay BB, Falkow S (1997) Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev 61:136\u2013169","journal-title":"Microbiol Mol Biol Rev"},{"key":"9992_CR61","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1574-6968.2000.tb09235.x","volume":"189","author":"I Tsarfaty","year":"2000","unstructured":"Tsarfaty I, Sandovsky-Losica H, Mittelman L, Berdicevsky I, Segal E (2000) Cellular actin is affected by interaction with Candida albicans. FEMS Microbiol Lett 189:225\u2013232. https:\/\/doi.org\/10.1111\/j.1574-6968.2000.tb09235.x","journal-title":"FEMS Microbiol Lett"},{"key":"9992_CR62","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1128\/IAI.70.6.3156-3163.2002","volume":"70","author":"JA Wasylnka","year":"2002","unstructured":"Wasylnka JA, Moore MM (2002) Uptake of Aspergillus fumigatus conidia by phagocytic and nonphagocytic cells in vitro: quantitation using strains expressing green fluorescent protein. Infect Immun 70:3156\u20133163. https:\/\/doi.org\/10.1128\/IAI.70.6.3156-3163.2002","journal-title":"Infect Immun"},{"key":"9992_CR63","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.micinf.2004.05.005","volume":"6","author":"MJS Mendes-Giannini","year":"2004","unstructured":"Mendes-Giannini MJS, Hanna SA, da Silva JLM, Andreotti PF, Vincenzi LR, Benard G, Lenzi HL, Soares CP (2004) Invasion of epithelial mammalian cells by Paracoccidioides brasiliensis leads to cytoskeletal rearrangement and apoptosis of the host cell. Microbes Infect 6:882\u2013891. https:\/\/doi.org\/10.1016\/j.micinf.2004.05.005","journal-title":"Microbes Infect"},{"key":"9992_CR64","doi-asserted-by":"publisher","first-page":"a019687","DOI":"10.1101\/cshperspect.a019687","volume":"5","author":"DC Sheppard","year":"2015","unstructured":"Sheppard DC, Filler SG (2015) Host cell invasion by medically important fungi. Cold Spring Harb Perspect Med 5:a019687. https:\/\/doi.org\/10.1101\/cshperspect.a019687","journal-title":"Cold Spring Harb Perspect Med"},{"key":"9992_CR65","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1462-5822.2009.01394.x","volume":"12","author":"F Dalle","year":"2010","unstructured":"Dalle F, W\u00e4chtler B, L\u2019ollivier C, Holland G, Bannert N, Wilson D, Labru\u00e8re C, Bonnin A, Hube B (2010) Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol 12:248\u2013271. https:\/\/doi.org\/10.1111\/j.1462-5822.2009.01394.x","journal-title":"Cell Microbiol"},{"key":"9992_CR66","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1128\/IAI.00001-10","volume":"78","author":"C McKenzie","year":"2010","unstructured":"McKenzie C, Koser U, Lewis L, Bain J, Mora-Montes H, Barker R, Gow N, Erwig L (2010) Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages. Infect Immun 78:1650\u20131658. https:\/\/doi.org\/10.1128\/IAI.00001-10","journal-title":"Infect Immun"},{"key":"9992_CR67","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1128\/EC.3.5.1076-1087.2004","volume":"3","author":"MC Lorenz","year":"2004","unstructured":"Lorenz MC, Bender JA, Fink GR (2004) Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot Cell 3:1076\u20131087. https:\/\/doi.org\/10.1128\/EC.3.5.1076-1087.2004","journal-title":"Eukaryot Cell"},{"key":"9992_CR68","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1371\/journal.pbio.0050064","volume":"5","author":"QT Phan","year":"2007","unstructured":"Phan QT, Myers CL, Fu Y, Sheppard DC, Yeaman MR, Welch WH, Ibrahim AS, Edwards JE Jr, Filler SG (2007) Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 5:e64. https:\/\/doi.org\/10.1371\/journal.pbio.0050064","journal-title":"PLoS Biol"},{"key":"9992_CR69","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1462-5822.2004.00476.x","volume":"7","author":"H Park","year":"2005","unstructured":"Park H, Myers CL, Sheppard DC, Phan QT, Sanchez AA, Edwards JE, Filler SG (2005) Role of the fungal Rasprotein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell Microbiol 7:499\u2013510. https:\/\/doi.org\/10.1111\/j.1462-5822.2004.00476.x","journal-title":"Cell Microbiol"},{"key":"9992_CR70","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0966-842X(01)02035-2","volume":"9","author":"M Feldmesser","year":"2001","unstructured":"Feldmesser M, Tucker S, Casadevall A (2001) Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol 9:273\u2013278. https:\/\/doi.org\/10.1016\/S0966-842X(01)02035-2","journal-title":"Trends Microbiol"},{"key":"9992_CR71","doi-asserted-by":"publisher","first-page":"e00167-00111","DOI":"10.1128\/mBio.00167-11","volume":"2","author":"AM Nicola","year":"2011","unstructured":"Nicola AM, Robertson EJ, Albuquerque P, da Silveira Derengowski L, Casadevall A (2011) Nonlytic exocytosis of Cryptococcus neoformans from macrophages occurs in vivo and is influenced by phagosomal pH. MBio 2:e00167-00111. https:\/\/doi.org\/10.1128\/mBio.00167-11","journal-title":"MBio"},{"key":"9992_CR72","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1128\/CMR.12.1.40","volume":"12","author":"DJ Sheehan","year":"1999","unstructured":"Sheehan DJ, Hitchcock CA, Sibley CM (1999) Current and emerging azole antifungal agents. Clin Microbiol Rev 12:40\u201379. https:\/\/doi.org\/10.1128\/CMR.12.1.40","journal-title":"Clin Microbiol Rev"},{"key":"9992_CR73","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1128\/CMR.1.2.187","volume":"1","author":"RA Fromtling","year":"1988","unstructured":"Fromtling RA (1988) Overview of medically important antifungal azole derivatives. Clin Microbiol Rev 1:187\u2013217. https:\/\/doi.org\/10.1128\/CMR.1.2.187","journal-title":"Clin Microbiol Rev"},{"key":"9992_CR74","doi-asserted-by":"publisher","first-page":"1800200","DOI":"10.1002\/ardp.201800200","volume":"351","author":"F Turkan","year":"2018","unstructured":"Turkan F, Cetin A, Taslimi P, Gul\u00e7in \u0130 (2018) Some pyrazoles derivatives: potent carbonic anhydrase, \u03b1-glycosidase, and cholinesterase enzymes inhibitors. Arch Pharma 351:1800200. https:\/\/doi.org\/10.1002\/ardp.201800200","journal-title":"Arch Pharma"},{"key":"9992_CR75","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.bioorg.2019.02.013","volume":"86","author":"F Turkan","year":"2019","unstructured":"Turkan F, Cetin A, Taslimi P, Karaman M, Gul\u00e7in \u0130 (2019) Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors. Bioorg Chem 86:420\u2013427. https:\/\/doi.org\/10.1016\/j.bioorg.2019.02.013","journal-title":"Bioorg Chem"},{"key":"9992_CR76","doi-asserted-by":"publisher","first-page":"1800292","DOI":"10.1002\/ardp.201800292","volume":"352","author":"E G\u00fczel","year":"2019","unstructured":"G\u00fczel E, Ko\u00e7yi\u011fit \u00dcM, Arslan BS, Ata\u015f M, Taslimi P, G\u00f6kalp F, Nebio\u011flu M, \u015ei\u015fman \u0130, Gul\u00e7in \u0130 (2019) Aminopyrazole-substituted metallophthalocyanines: preparation, aggregation behavior, and investigation of metabolic enzymes inhibition properties. Arch Pharm 352:1800292. https:\/\/doi.org\/10.1002\/ardp.201800292","journal-title":"Arch Pharm"},{"key":"9992_CR77","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bioorg.2019.01.044","volume":"86","author":"B Kuzu","year":"2019","unstructured":"Kuzu B, Tan M, Taslimi P, G\u00fcl\u00e7in \u0130, Ta\u015fp\u0131nar M, Menges N (2019) Mono- or di-substituted imidazole derivatives for inhibition of acetylcholine and butyrylcholine esterases. Bioorg Chem 86:187\u2013196. https:\/\/doi.org\/10.1016\/j.bioorg.2019.01.044","journal-title":"Bioorg Chem"},{"key":"9992_CR78","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.bmcl.2007.01.074","volume":"17","author":"RK Ujjinamatada","year":"2007","unstructured":"Ujjinamatada RK, Baier A, Borowski P, Hosmane RS (2007) An analogue of AICAR with dual inhibitory activity against WNV and HCV NTPase\/helicase: synthesis and in vitro screening of 4-carbamoyl-5-(4,6-diamino-2,5-dihydro-1,3,5-triazin-2-yl) imidazole-1-\u03b2-d-ribofuranoside. Bioorg Med Chem Lett 17:2285\u20132288. https:\/\/doi.org\/10.1016\/j.bmcl.2007.01.074","journal-title":"Bioorg Med Chem Lett"},{"key":"9992_CR79","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bmcl.2007.10.111","volume":"18","author":"S Emami","year":"2008","unstructured":"Emami S, Foroumadi A, Falahati M, Lotfali E, Rajabalian S, Ebrahimi S-A, Farahyar S, Shafiee A (2008) 2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents. Bioorg Med Chem Lett 18:141\u2013146. https:\/\/doi.org\/10.1016\/j.bmcl.2007.10.111","journal-title":"Bioorg Med Chem Lett"},{"key":"9992_CR80","doi-asserted-by":"publisher","first-page":"e22239","DOI":"10.1002\/jbt.22239","volume":"33","author":"\u0130 Timur","year":"2019","unstructured":"Timur \u0130, Kocyigit \u00dcM, Dastan T, Sandal S, Ceribas\u0131 AO, Taslimi P, Gulcin \u0130, Koparir M, Karatepe M, \u00c7ift\u00e7i M (2019) In vitro cytotoxic and in vivo antitumoral activities of some aminomethyl derivatives of 2,4-dihydro-3H-1,2,4-triazole-3-thiones\u2014evaluation of their acetylcholinesterase and carbonic anhydrase enzymes inhibition profiles. J Biochem Mol Toxicol 33:e22239. https:\/\/doi.org\/10.1002\/jbt.22239","journal-title":"J Biochem Mol Toxicol"},{"key":"9992_CR81","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1016\/j.ejmech.2009.05.021","volume":"44","author":"RV Shingalapur","year":"2009","unstructured":"Shingalapur RV, Hosamani KM, Keri RS (2009) Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles. Eur J Med Chem 44:4244\u20134248. https:\/\/doi.org\/10.1016\/j.ejmech.2009.05.021","journal-title":"Eur J Med Chem"},{"key":"9992_CR82","doi-asserted-by":"publisher","first-page":"e22009","DOI":"10.1002\/jbt.22009","volume":"32","author":"Y Sar\u0131","year":"2018","unstructured":"Sar\u0131 Y, Akta\u015f A, Taslimi P, G\u00f6k Y, Gul\u00e7in \u0130 (2018) Novel N-propylphthalimide- and 4-vinylbenzyl-substituted benzimidazole salts: synthesis, characterization, and determination of their metal chelating effects and inhibition profiles against acetylcholinesterase and carbonic anhydrase enzymes. J Biochem Mol Toxicol 32:e22009. https:\/\/doi.org\/10.1002\/jbt.22009","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"9992_CR83","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.3109\/14756366.2015.1132210","volume":"31","author":"Y G\u00f6k","year":"2016","unstructured":"G\u00f6k Y, Akko\u00e7 S, Erdo\u011fan H, Albayrak S (2016) In vitro antimicrobial studies of new benzimidazolium salts and silver N-heterocyclic carbene complexes. J Enzym Inhib Med Chem 31(6):1322\u20131327. https:\/\/doi.org\/10.3109\/14756366.2015.1132210","journal-title":"J Enzym Inhib Med Chem"},{"key":"9992_CR84","doi-asserted-by":"publisher","first-page":"1800029","DOI":"10.1002\/ardp.201800029","volume":"351","author":"F T\u00fcrker","year":"2018","unstructured":"T\u00fcrker F, Barut Celepci D, Akta\u015f A, Taslimi P, G\u00f6k Y, Ayg\u00fcn M, G\u00fcl\u00e7in \u0130 (2018) Meta-cyanobenzyl substituted benzimidazolium salts: synthesis, characterization, crystal structure and carbonic anhydrase, \u03b1-glycosidase, butyrylcholinesterase, and acetylcholinesterase inhibitory properties. Arch Pharm 351:1800029. https:\/\/doi.org\/10.1002\/ardp.201800029","journal-title":"Arch Pharm"},{"key":"9992_CR85","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/clinids\/2.4.520","volume":"2","author":"M Borgers","year":"1980","unstructured":"Borgers M (1980) Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Rev Infect Dis 2:520\u2013534. https:\/\/doi.org\/10.1093\/clinids\/2.4.520","journal-title":"Rev Infect Dis"},{"key":"9992_CR86","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1016\/0006-2952(82)90707-9","volume":"31","author":"H Van den Bossche","year":"1982","unstructured":"Van den Bossche H, Ruysschaert JM, Defrise-Quertain F, Willemsens G, Cornelissen F, Marichal P, Cools W, Van Cutsem J (1982) The interaction of miconazole and ketoconazole with lipids. Biochem Pharma 31:2609\u20132617. https:\/\/doi.org\/10.1016\/0006-2952(82)90707-9","journal-title":"Biochem Pharma"},{"key":"9992_CR87","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/13693780500138971","volume":"43","author":"RA Akins","year":"2005","unstructured":"Akins RA (2005) An update on antifungal targets and mechanisms of resistance in Candida albicans. Med Mycol 43:285\u2013318. https:\/\/doi.org\/10.1080\/13693780500138971","journal-title":"Med Mycol"},{"key":"9992_CR88","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1128\/AAC.48.10.3690-3696.2004","volume":"48","author":"HK Munayyer","year":"2004","unstructured":"Munayyer HK, Mann PA, Chau AS, Yarosh-Tomaine T, Greene JR, Hare RS, Heimark L, Palermo RE, Loebenberg D, McNicholas PM (2004) Posaconazole is a potent inhibitor of sterol 14\u03b1-demethylation in yeasts and molds. Antimicrob Agents Chemother 48:3690\u20133696. https:\/\/doi.org\/10.1128\/AAC.48.10.3690-3696.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"9992_CR89","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1439-0507.2006.01295.x","volume":"49","author":"H Hof","year":"2006","unstructured":"Hof H (2006) A new, broad-spectrum azole antifungal: posaconazole\u2013mechanisms of action and resistance, spectrum of activity. Mycoses 49:2\u20136. https:\/\/doi.org\/10.1111\/j.1439-0507.2006.01295.x","journal-title":"Mycoses"},{"key":"9992_CR90","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/713687","author":"P Vandeputte","year":"2011","unstructured":"Vandeputte P, Ferrari S, Coste AT (2011) Antifungal resistance and new strategies to control fungal infections. Int J Microbiol. https:\/\/doi.org\/10.1155\/2012\/713687","journal-title":"Int J Microbiol"},{"key":"9992_CR91","first-page":"447","volume":"19","author":"R Brown","year":"1957","unstructured":"Brown R, Hazen EL (1957) Present knowledge of nystatin, an antifungal antibiotic. Trans NY Acad Sci 19:447\u2013456","journal-title":"Trans NY Acad Sci"},{"key":"9992_CR92","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/jid.1955.77","volume":"24","author":"MB Sloane","year":"1955","unstructured":"Sloane MB (1955) A new antifungal antibiotic, mycostatin (nystatin), ior the treatment of moniliasis: a preliminary report. J Investig Dermatol 24:569\u2013571. https:\/\/doi.org\/10.1038\/jid.1955.77","journal-title":"J Investig Dermatol"},{"key":"9992_CR93","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","volume":"68","author":"A Lemke","year":"2005","unstructured":"Lemke A, Kiderlen A, Kayser O (2005) Amphotericin B. Appl Microbiol Biotechnol 68:151\u2013162. https:\/\/doi.org\/10.1007\/s00253-005-1955-9","journal-title":"Appl Microbiol Biotechnol"},{"key":"9992_CR94","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","volume":"2","author":"D Sanglard","year":"2002","unstructured":"Sanglard D, Odds FC (2002) Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2:73\u201385. https:\/\/doi.org\/10.1016\/S1473-3099(02)00181-0","journal-title":"Lancet Infect Dis"},{"key":"9992_CR95","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jiac.2018.04.014","volume":"24","author":"H Kato","year":"2018","unstructured":"Kato H, Hagihara M, Yamagishi Y, Shibata Y, Kato Y, Furui T, Watanabe H, Asai N, Koizumi Y, Mikamo H (2018) The evaluation of frequency of nephrotoxicity caused by liposomal amphotericin B. J Infect Chemother 24:725\u2013728. https:\/\/doi.org\/10.1016\/j.jiac.2018.04.014","journal-title":"J Infect Chemother"},{"key":"9992_CR96","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1517\/13543776.12.2.151","volume":"12","author":"HV Bossche","year":"2002","unstructured":"Bossche HV (2002) Echinocandins: an update. Expert Opin Ther Pat 12:151\u2013167. https:\/\/doi.org\/10.1517\/13543776.12.2.151","journal-title":"Expert Opin Ther Pat"},{"key":"9992_CR97","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","volume":"362","author":"DW Denning","year":"2003","unstructured":"Denning DW (2003) Echinocandin antifungal drugs. Lancet 362:1142\u20131151. https:\/\/doi.org\/10.1016\/S0140-6736(03)14472-8","journal-title":"Lancet"},{"key":"9992_CR98","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1128\/AAC.41.11.2471","volume":"41","author":"C Douglas","year":"1997","unstructured":"Douglas C, D\u2019ippolito J, Shei G, Meinz M, Onishi J, Marrinan J, Li W, Abruzzo G, Flattery A, Bartizal K (1997) Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-d-glucan synthase inhibitors. Antimicrob Agents Chemother 41:2471\u20132479. https:\/\/doi.org\/10.1128\/AAC.41.11.2471","journal-title":"Antimicrob Agents Chemother"},{"key":"9992_CR99","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/0253-7613.62396","volume":"42","author":"ND Grover","year":"2010","unstructured":"Grover ND (2010) Echinocandins: a ray of hope in antifungal drug therapy. Indian J Pharmacol 42:9\u201311. https:\/\/doi.org\/10.4103\/0253-7613.62396","journal-title":"Indian J Pharmacol"},{"key":"9992_CR100","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/jac\/dkf045","volume":"49","author":"DW Denning","year":"2002","unstructured":"Denning DW (2002) Echinocandins: a new class of antifungal. J Antimicrob Chemother 49:889\u2013891. https:\/\/doi.org\/10.1093\/jac\/dkf045","journal-title":"J Antimicrob Chemother"},{"key":"9992_CR101","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jac\/46.2.171","volume":"46","author":"A Vermes","year":"2000","unstructured":"Vermes A, Guchelaar HJ, Dankert J (2000) Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 46:171\u2013179. https:\/\/doi.org\/10.1093\/jac\/46.2.171","journal-title":"J Antimicrob Chemother"},{"key":"9992_CR102","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1128\/AAC.44.2.368-377.2000","volume":"44","author":"J Onishi","year":"2000","unstructured":"Onishi J, Meinz M, Thompson J, Curotto J, Dreikorn S, Rosenbach M, Douglas C, Abruzzo G, Flattery A, Kong L (2000) Discovery of novel antifungal (1,3)-\u03b2-d-glucan synthase inhibitors. Antimicrob Agents Chemother 44:368\u2013377. https:\/\/doi.org\/10.1128\/AAC.44.2.368-377.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"9992_CR103","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1567-1364.2009.00578.x","volume":"9","author":"D Sanglard","year":"2009","unstructured":"Sanglard D, Coste A, Ferrari S (2009) Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 9:1029\u20131050. https:\/\/doi.org\/10.1111\/j.1567-1364.2009.00578.x","journal-title":"FEMS Yeast Res"},{"key":"9992_CR104","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1749-6632.1988.tb40405.x","volume":"544","author":"NS Ryder","year":"1988","unstructured":"Ryder NS (1988) Mechanism of action and biochemical selectivity of allylamine antimycotic agents. Ann NY Acad Sci 544:208\u2013220. https:\/\/doi.org\/10.1111\/j.1749-6632.1988.tb40405.x","journal-title":"Ann NY Acad Sci"},{"key":"9992_CR105","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0031-9422(00)84762-7","volume":"26","author":"RI Baloch","year":"1987","unstructured":"Baloch RI, Mercer EI (1987) Inhibition of sterol \u03948\u2009\u2192\u2009\u03947-isomerase and \u039414-reductase by fenpropimorph tridemorph and fenpropidin in cell-free enzyme systems from Saccharomyces cerevisiae. Phytochemistry 26:663\u2013668. https:\/\/doi.org\/10.1016\/S0031-9422(00)84762-7","journal-title":"Phytochemistry"},{"key":"9992_CR106","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-642-75458-6_8","volume-title":"Chemotherapy of fungal diseases. Handbook of experimental pharmacology","author":"A Polak","year":"1990","unstructured":"Polak A (1990) Mode of action studies. In: Ryley JF (ed) Chemotherapy of fungal diseases. Handbook of experimental pharmacology, vol 96. Springer, Berlin, pp 153\u2013182. https:\/\/doi.org\/10.1007\/978-3-642-75458-6_8"},{"key":"9992_CR107","volume-title":"Trease and evans\u2019 pharmacognosy E-book","author":"WC Evans","year":"2009","unstructured":"Evans WC (2009) Trease and evans\u2019 pharmacognosy E-book. Els Health Sci, Saunders Ltd., London"},{"key":"9992_CR108","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1042\/bj0680067","volume":"68","author":"J Mead","year":"1958","unstructured":"Mead J, Smith J, Williams R (1958) Studies in detoxication. 72. The metabolism of coumarin and of o-coumaric acid. Biochem J 68:67\u201374. https:\/\/doi.org\/10.1042\/bj0680067","journal-title":"Biochem J"},{"key":"9992_CR109","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/963248","author":"KN Venugopala","year":"2013","unstructured":"Venugopala KN, Rashmi V, Odhav B (2013) Review on natural coumarin lead compounds for their pharmacological activity. Biomed Res Int. https:\/\/doi.org\/10.1155\/2013\/963248","journal-title":"Biomed Res Int"},{"key":"9992_CR110","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1039\/np9890600591","volume":"6","author":"R Murray","year":"1989","unstructured":"Murray R (1989) Coumarins. Nat Prod Rep 6:591\u2013624","journal-title":"Nat Prod Rep"},{"key":"9992_CR111","first-page":"554","volume":"56","author":"N Piller","year":"1975","unstructured":"Piller N (1975) A comparison of the effectiveness of some anti-inflammatory drugs on thermal oedema. Br J Exp Pathol 56:554\u2013559","journal-title":"Br J Exp Pathol"},{"key":"9992_CR112","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1021\/bi00601a003","volume":"17","author":"D Whitlon","year":"1978","unstructured":"Whitlon D, Sadowski J, Suttie J (1978) Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition. Biochemistry 17:1371\u20131377. https:\/\/doi.org\/10.1021\/bi00601a003","journal-title":"Biochemistry"},{"key":"9992_CR113","first-page":"86","volume":"16","author":"K Hodak","year":"1967","unstructured":"Hodak K, Jakesov\u00e1 V, Dad\u00e1k V (1967) On the antibiotic effects of natural coumarins. VI. The relation of structure to the antibacterial effects of some natural coumarins and the neutralization of such effects. Cesk Farm 16:86\u201391","journal-title":"Cesk Farm"},{"key":"9992_CR114","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1080\/10286020903158964","volume":"11","author":"CM Wang","year":"2009","unstructured":"Wang CM, Zhou W, Li CX, Chen H, Shi ZQ, Fan YJ (2009) Efficacy of osthol, a potent coumarin compound, in controlling powdery mildew caused by Sphaerotheca fuliginea. J Asian Nat Prod Res 11:783\u2013791. https:\/\/doi.org\/10.1080\/10286020903158964","journal-title":"J Asian Nat Prod Res"},{"key":"9992_CR115","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1021\/jm00078a001","volume":"36","author":"AD Patil","year":"1993","unstructured":"Patil AD, Freyer AJ, Eggleston DS, Haltiwanger RC, Bean MF, Taylor PB, Caranfa MJ, Breen AL, Bartus HR (1993) The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. J Med Chem 36:4131\u20134138. https:\/\/doi.org\/10.1021\/jm00078a001","journal-title":"J Med Chem"},{"key":"9992_CR116","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1021\/jm00093a004","volume":"35","author":"Y Kashman","year":"1992","unstructured":"Kashman Y, Gustafson KR, Fuller R, McMahon J, Currens M, Buckheit JR, Hughes S, Cragg G, Boyd M (1992) The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J Med Chem 35:2735\u20132743. https:\/\/doi.org\/10.1021\/jm00093a004","journal-title":"J Med Chem"},{"key":"9992_CR117","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1248\/bpb.33.1610","volume":"33","author":"E Shin","year":"2010","unstructured":"Shin E, Choi K-M, Yoo H-S, Lee C-K, Hwang BY, Lee MK (2010) Inhibitory effects of coumarins from the stem barks of Fraxinus rhynchophylla on adipocyte differentiation in 3T3-L1 cells. Biol Pharm Bull 33:1610\u20131614. https:\/\/doi.org\/10.1248\/bpb.33.1610","journal-title":"Biol Pharm Bull"},{"key":"9992_CR118","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.eplepsyres.2009.03.027","volume":"85","author":"JJ Luszczki","year":"2009","unstructured":"Luszczki JJ, Wojda E, Andres-Mach M, Cisowski W, Glensk M, Glowniak K, Czuczwar SJ (2009) Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: a comparative study. Epile Res 85:293\u2013299. https:\/\/doi.org\/10.1016\/j.eplepsyres.2009.03.027","journal-title":"Epile Res"},{"key":"9992_CR119","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3390\/molecules14030939","volume":"14","author":"A Basile","year":"2009","unstructured":"Basile A, Sorbo S, Spadaro V, Bruno M, Maggio A, Faraone N, Rosselli S (2009) Antimicrobial and antioxidant activities of coumarins from the roots of Ferulago campestris (Apiaceae). Mol 14:939\u2013952. https:\/\/doi.org\/10.3390\/molecules14030939","journal-title":"Mol"},{"key":"9992_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-9422(00)84417-9","author":"N Finkelstein","year":"1976","unstructured":"Finkelstein N, Rivett DE (1976) Puberulin, a new prenyloxy-coumarin from Agathosma puberula. Phytochemistry. https:\/\/doi.org\/10.1016\/S0031-9422(00)84417-9","journal-title":"Phytochemistry"},{"key":"9992_CR121","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11101-006-9040-2","volume":"5","author":"F Bourgaud","year":"2006","unstructured":"Bourgaud F, Hehn A, Larbat R, Doerper S, Gontier E, Kellner S, Matern U (2006) Biosynthesis of coumarins in plants: a major pathway still to be unravelled for cytochrome P450 enzymes. Phytochem Rev 5:293\u2013308. https:\/\/doi.org\/10.1007\/s11101-006-9040-2","journal-title":"Phytochem Rev"},{"key":"9992_CR122","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2174\/1568026618666180329115523","volume":"18","author":"TM Pereira","year":"2018","unstructured":"Pereira TM, Franco DP, Vitorio F, Kummerle AE (2018) Coumarin compounds in medicinal chemistry: some important examples from the last years. Curr Top Med Chem 18:124\u2013148. https:\/\/doi.org\/10.2174\/1568026618666180329115523","journal-title":"Curr Top Med Chem"},{"key":"9992_CR123","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.1007\/s00253-016-7660-z","volume":"100","author":"TM Costa","year":"2016","unstructured":"Costa TM, Tavares LBB, de Oliveira D (2016) Fungi as a source of natural coumarins production. App Microbiol Biotechnol 100:6571\u20136584. https:\/\/doi.org\/10.1007\/s00253-016-7660-z","journal-title":"App Microbiol Biotechnol"},{"key":"9992_CR124","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5772\/59982","volume":"5","author":"MJ Matos","year":"2015","unstructured":"Matos MJ, Santana L, Uriarte E, Abreu OA, Molina E, Yordi EG (2015) Coumarins-An important class of phytochemicals, phytochemicals. IntechOpen 5:113\u2013140. https:\/\/doi.org\/10.5772\/59982","journal-title":"IntechOpen"},{"key":"9992_CR125","unstructured":"Yang J, Sun X, Yang F, Liu C (2013) New agrochemicals disclosed in 2012. (State Key Laboratory of the Discovery and Development of Novel Pesticide, Shenyang Research Institute of Chemical Industry Co., Ltd., Shenyang 110021, China). Agrochemical 2013-01"},{"key":"9992_CR126","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.2174\/1381612811319210013","volume":"19","author":"XM Peng","year":"2013","unstructured":"Peng XM, Damu GLV, Zhou H (2013) Current developments of coumarin compounds in medicinal chemistry. Curr Pharm Des 19:3884\u20133930. https:\/\/doi.org\/10.2174\/1381612811319210013","journal-title":"Curr Pharm Des"},{"key":"9992_CR127","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1021\/acsomega.7b00562","volume":"2","author":"C Stiefel","year":"2017","unstructured":"Stiefel C, Schubert T, Morlock GE (2017) Bioprofiling of cosmetics with focus on streamlined coumarin analysis. ACS Omega 2:5242\u20135250. https:\/\/doi.org\/10.1021\/acsomega.7b00562","journal-title":"ACS Omega"},{"key":"9992_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471238961.0315211302150919.a01","volume":"4","author":"PM Boisde","year":"2000","unstructured":"Boisde PM, Meuly WC, Ub Staff (2000) Coumarin. Kirk-Othmer Encycl Chem Technol 4:1\u201310. https:\/\/doi.org\/10.1002\/0471238961.0315211302150919.a01","journal-title":"Kirk-Othmer Encycl Chem Technol"},{"key":"9992_CR129","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2903\/j.efsa.2008.793","volume":"6","author":"Authority EFS","year":"2008","unstructured":"Authority EFS (2008) Coumarin in flavourings and other food ingredients with flavouring properties-Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC). EFSA J 6:793. https:\/\/doi.org\/10.2903\/j.efsa.2008.793","journal-title":"EFSA J"},{"key":"9992_CR130","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tet.2014.12.042","volume":"71","author":"X He","year":"2015","unstructured":"He X, Shang Y, Zhou Y, Yu Z, Han G, Jin W, Chen J (2015) Synthesis of coumarin-3-carboxylic esters via FeCl3-catalyzed multicomponent reaction of salicylaldehydes, Meldrum\u2019s acid and alcohols. Tetrahedron 71:863\u2013868. https:\/\/doi.org\/10.1016\/j.tet.2014.12.042","journal-title":"Tetrahedron"},{"key":"9992_CR131","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1016\/j.bmc.2014.05.032","volume":"22","author":"S Sandhu","year":"2014","unstructured":"Sandhu S, Bansal Y, Silakari O, Bansal G (2014) Coumarin hybrids as novel therapeutic agents. Bioorg Med Chem 22:3806\u20133814. https:\/\/doi.org\/10.1016\/j.bmc.2014.05.032","journal-title":"Bioorg Med Chem"},{"key":"9992_CR132","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.bmc.2011.12.042","volume":"20","author":"P Anand","year":"2012","unstructured":"Anand P, Singh B, Singh N (2012) A review on coumarins as acetylcholinesterase inhibitors for Alzheimer\u2019s disease. Bioorg Med Chem 20:1175\u20131180. https:\/\/doi.org\/10.1016\/j.bmc.2011.12.042","journal-title":"Bioorg Med Chem"},{"key":"9992_CR133","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s10562-007-9307-2","volume":"121","author":"K Upadhyay","year":"2008","unstructured":"Upadhyay K, Mishra RK, Kumar A (2008) A convenient synthesis of some coumarin derivatives using SnCl2\u00b72H2O as catalyst. Catal Lett 121:118\u2013120. https:\/\/doi.org\/10.1007\/s10562-007-9307-2","journal-title":"Catal Lett"},{"key":"9992_CR134","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/BF03246160","volume":"6","author":"A Shaabani","year":"2009","unstructured":"Shaabani A, Ghadari R, Rahmati A, Rezayan A (2009) Coumarin synthesis via Knoevenagel condensation reaction in 1,1,3,3-N,N,N\u2032,N\u2032-tetramethylguanidinium trifluoroacetate ionic liquid. J Iran Chem Soc 6:710\u2013714. https:\/\/doi.org\/10.1007\/BF03246160","journal-title":"J Iran Chem Soc"},{"key":"9992_CR135","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1248\/cpb.42.2170","volume":"42","author":"T Harayama","year":"1994","unstructured":"Harayama T, Nakatsuka K, Nishioka H, Murakami K, Hayashida N, Ishii H (1994) Convenient synthesis of a simple coumarin from salicylaldehyde and wittig reagent. II. Synthesis of bromo-and methoxycarbonylcoumarins. Chem Pharm Bull 42:2170\u20132173. https:\/\/doi.org\/10.1248\/cpb.42.2170","journal-title":"Chem Pharm Bull"},{"key":"9992_CR136","unstructured":"Ghantwal S, Samant S (1999) Claisen rearrangement of 3-bromo-,3, 6-dibromo-,3,8-dibromo-and 8-iodo\/aminomethyl\/acetyl-7-allyloxy-4-methylcoumarins. NISCAIR-CSIR, India, pp 1242\u20131247. http:\/\/hdl.handle.net\/123456789\/16650 . Accessed Nov 1999"},{"key":"9992_CR137","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0143-7208(95)00060-7","volume":"30","author":"M Bulut","year":"1996","unstructured":"Bulut M, Erk C (1996) Improved synthesis of some hydroxycoumarins. Dyes Pigm 30:99\u2013104. https:\/\/doi.org\/10.1016\/0143-7208(95)00060-7","journal-title":"Dyes Pigm"},{"issue":"6","key":"9992_CR138","first-page":"74","volume":"4","author":"RI Al-Bayati","year":"2010","unstructured":"Al-Bayati RI, Al-Amiery AAH, Al-Majedy YK (2010) Design, synthesis and bioassay of novel coumarins. Afr J Pure Appl Chem 4(6):74\u201386","journal-title":"Afr J Pure Appl Chem"},{"key":"9992_CR139","doi-asserted-by":"publisher","DOI":"10.1039\/JR9310002426","author":"A Robertson","year":"1931","unstructured":"Robertson A, Sandrock WF, Hendry CB (1931) CCCXXX. Hydroxy-carbonyl compounds. Part V. The preparation of coumarins and 1:4-pyrones from phenol, p-cresol, quinol, and \u03b1-naphthol. J Chem Soc. https:\/\/doi.org\/10.1039\/JR9310002426","journal-title":"J Chem Soc"},{"key":"9992_CR140","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/i8050392","volume":"8","author":"VC Soares","year":"2007","unstructured":"Soares VC, Alves MB, Souza ER, Pinto IO, Rubim JC, Andrade CKZ, Suarez PA (2007) Organo-niobate ionic liquids: synthesis, characterization and application as acid catalyst in Pechmann reactions. Int J Mol Sci 8:392\u2013398. https:\/\/doi.org\/10.3390\/i8050392","journal-title":"Int J Mol Sci"},{"key":"9992_CR141","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1021\/jo01060a602","volume":"26","author":"E John","year":"1961","unstructured":"John E, Israelstam S (1961) Use of cation exchange resins in organic reactions. I. The Von Pechmann reaction. J Org Chem 26:240\u2013242. https:\/\/doi.org\/10.1021\/jo01060a602","journal-title":"J Org Chem"},{"key":"9992_CR142","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1081\/SCC-100107007","volume":"31","author":"BM Reddy","year":"2001","unstructured":"Reddy BM, Reddy VR, Giridhar D (2001) Synthesis of coumarins catalyzed by eco-friendly W\/ZrO2 solid acid catalyst. Synth Commun 31:3603\u20133607. https:\/\/doi.org\/10.1081\/SCC-100107007","journal-title":"Synth Commun"},{"key":"9992_CR143","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5530\/srp.2017.1.11","volume":"8","author":"YK Al-Majedy","year":"2017","unstructured":"Al-Majedy YK, Kadhum AAH, Al-Amiery AA, Mohamad AB (2017) Coumarins: the antimicrobial agents. Syst Rev Pharm 8:62\u201370. https:\/\/doi.org\/10.5530\/srp.2017.1.11","journal-title":"Syst Rev Pharm"},{"key":"9992_CR144","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/0306-3623(95)02112-4","volume":"27","author":"J Hoult","year":"1996","unstructured":"Hoult J, Paya M (1996) Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen Pharmacol Vasc Syst 27:713\u2013722. https:\/\/doi.org\/10.1016\/0306-3623(95)02112-4","journal-title":"Gen Pharmacol Vasc Syst"},{"key":"9992_CR145","doi-asserted-by":"publisher","first-page":"e80760","DOI":"10.1371\/journal.pone.0080760","volume":"8","author":"DK Mercer","year":"2013","unstructured":"Mercer DK, Robertson J, Wright K, Miller L, Smith S, Stewart CS, Deborah A (2013) A prodrug approach to the use of coumarins as potential therapeutics for superficial mycoses. PLoS ONE 8:e80760. https:\/\/doi.org\/10.1371\/journal.pone.0080760","journal-title":"PLoS ONE"},{"key":"9992_CR146","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.bjm.2017.06.009","volume":"49","author":"FQ Guerra","year":"2018","unstructured":"Guerra FQ, Ara\u00fajo RS, Sousa JP, Silva VA, Pereira FO, Mendon\u00e7a-Junior FJ, Barbosa-Filho JM, Pereira JA, Lima EO (2018) A new coumarin derivative, 4-acetatecoumarin, with antifungal activity and association study against Aspergillus spp. Braz J Microbiol 49:407\u2013413. https:\/\/doi.org\/10.1016\/j.bjm.2017.06.009","journal-title":"Braz J Microbiol"},{"key":"9992_CR147","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ejmech.2013.07.015","volume":"69","author":"KB Puttaraju","year":"2013","unstructured":"Puttaraju KB, Shivashankar K, Mahendra M, Rasal VP, Vivek PNV, Rai K, Chanu MB (2013) Microwave assisted synthesis of dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones; synthesis, in vitro antimicrobial and anticancer activities of novel coumarin substituted dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones. Eur J Med Chem 69:316\u2013322. https:\/\/doi.org\/10.1016\/j.ejmech.2013.07.015","journal-title":"Eur J Med Chem"},{"key":"9992_CR148","doi-asserted-by":"publisher","unstructured":"Marcondes HC, de Oliveira TT, Taylor JG, Hamoy M, do Leonel Neto A, de Mello VJ, Nagem TJ (2015) Antifungal activity of coumarin mammeisin isolated from species of the Kielmeyera Genre (family: Clusiaceae or Guttiferae). J Chem Article ID 241243. https:\/\/doi.org\/10.1155\/2015\/241243","DOI":"10.1155\/2015\/241243"},{"key":"9992_CR149","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0378-8741(00)00279-8","volume":"73","author":"T Ojala","year":"2000","unstructured":"Ojala T, Remes S, Haansuu P, Vuorela H, Hiltunen R, Haahtela K, Vuorela P (2000) Antimicrobial activity of some coumarin containing herbal plants growing in Finland. J Ethnopharmacol 73:299\u2013305. https:\/\/doi.org\/10.1016\/S0378-8741(00)00279-8","journal-title":"J Ethnopharmacol"},{"key":"9992_CR150","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.tiv.2007.01.022","volume":"21","author":"B Thati","year":"2007","unstructured":"Thati B, Noble A, Rowan R, Creaven BS, Walsh M, McCann M, Egan D, Kavanagh K (2007) Mechanism of action of coumarin and silver(I)\u2013coumarin complexes against the pathogenic yeast Candida albicans. Toxicol In Vitro 21:801\u2013808. https:\/\/doi.org\/10.1016\/j.tiv.2007.01.022","journal-title":"Toxicol In Vitro"},{"key":"9992_CR151","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejmech.2016.08.012","volume":"124","author":"MZ Zhang","year":"2016","unstructured":"Zhang MZ, Zhang RR, Wang JQ, Yu X, Zhang YL, Wang QQ, Zhang WH (2016) Microwave-assisted synthesis and antifungal activity of novel fused Osthole derivatives. Eur J Med Chem 124:10\u201316. https:\/\/doi.org\/10.1016\/j.ejmech.2016.08.012","journal-title":"Eur J Med Chem"},{"key":"9992_CR152","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/ardp.201000218","volume":"344","author":"ZN Siddiqui","year":"2011","unstructured":"Siddiqui ZN, Ahmad A, Khan AU (2011) Synthesis of 4-hydroxycoumarin heteroarylhybrids as potential antimicrobial agents. Arch Pharma 344:394\u2013401. https:\/\/doi.org\/10.1002\/ardp.201000218","journal-title":"Arch Pharma"},{"key":"9992_CR153","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0007-1536(73)80116-0","volume":"61","author":"SM Dietrich","year":"1973","unstructured":"Dietrich SM, Valio I (1973) Effect of coumarin and its derivatives on the growth of Pythium and other fungi. Trans Br Mycol Soc 61:461\u2013469. https:\/\/doi.org\/10.1016\/S0007-1536(73)80116-0","journal-title":"Trans Br Mycol Soc"},{"key":"9992_CR154","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/200800b0","volume":"200","author":"J Knypl","year":"1963","unstructured":"Knypl J (1963) A fungistatic action of coumarin. Nature 200:800\u2013802. https:\/\/doi.org\/10.1038\/200800b0","journal-title":"Nature"},{"key":"9992_CR155","doi-asserted-by":"publisher","unstructured":"Guerra FQS, Ara\u00fajo RSAD, Sousa JPD, Pereira FDO, Mendon\u00e7a-Junior FJ, Barbosa-Filho JM, de Oliveira Lima E (2015) Evaluation of antifungal activity and mode of action of new coumarin derivative, 7-hydroxy-6-nitro-2h-1-benzopyran-2-one, against Aspergillus spp. Evid Based Complement Altern Med Article ID 925096. https:\/\/doi.org\/10.1155\/2015\/925096","DOI":"10.1155\/2015\/925096"},{"key":"9992_CR156","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ijantimicag.2007.07.019","volume":"30","author":"PL Shao","year":"2007","unstructured":"Shao PL, Huang LM, Hsueh PR (2007) Recent advances and challenges in the treatment of invasive fungal infections. Int J Antimicrob Agents 30:487\u2013495. https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.07.019","journal-title":"Int J Antimicrob Agents"},{"key":"9992_CR157","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0733-8635(18)30996-3","volume":"2","author":"JC Henry","year":"1984","unstructured":"Henry JC (1984) Ketoconazole. Dermatol Clin 2:121\u2013128. https:\/\/doi.org\/10.1016\/S0733-8635(18)30996-3","journal-title":"Dermatol Clin"},{"key":"9992_CR158","first-page":"90","volume":"6","author":"R Zaragoza","year":"2008","unstructured":"Zaragoza R, Pem\u00e1n J (2008) The diagnostic and therapeutic approach to fungal infections in critical care settings. Adv Sepsis 6:90\u201398","journal-title":"Adv Sepsis"},{"key":"9992_CR159","first-page":"242","volume":"7","author":"MA Ghannoum","year":"2002","unstructured":"Ghannoum MA, Kuhn D (2002) Voriconazole\u2014better chances for patients with invasive mycoses. Eur J Med Res 7:242\u2013256","journal-title":"Eur J Med Res"},{"key":"9992_CR160","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1086\/324620","volume":"34","author":"DW Denning","year":"2002","unstructured":"Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, Haas A, Ruhnke M, Lode H (2002) Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34:563\u2013571. https:\/\/doi.org\/10.1086\/324620","journal-title":"Clin Infect Dis"},{"key":"9992_CR161","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ccm.2009.02.001","volume":"30","author":"GR Thompson","year":"2009","unstructured":"Thompson GR, Cadena J, Patterson TF (2009) Overview of antifungal agents. Clin Chest Med 30:203\u2013215. https:\/\/doi.org\/10.1016\/j.ccm.2009.02.001","journal-title":"Clin Chest Med"},{"key":"9992_CR162","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2165\/00003495-200565110-00007","volume":"65","author":"GM Keating","year":"2005","unstructured":"Keating GM (2005) Posaconazole. Drugs 65:1553\u20131567. https:\/\/doi.org\/10.2165\/00003495-200565110-00007","journal-title":"Drugs"},{"key":"9992_CR163","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S1473-3099(05)70297-8","volume":"5","author":"HA Torres","year":"2005","unstructured":"Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II (2005) Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis 5:775\u2013785. https:\/\/doi.org\/10.1016\/S1473-3099(05)70297-8","journal-title":"Lancet Infect Dis"},{"key":"9992_CR164","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1128\/AAC.44.10.2883-2886.2000","volume":"44","author":"T Yamazumi","year":"2000","unstructured":"Yamazumi T, Pfaller M, Messer S, Houston A, Hollis R, Jones R (2000) In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans. Antimicrob Agents Chemother 44:2883\u20132886. https:\/\/doi.org\/10.1128\/AAC.44.10.2883-2886.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"9992_CR165","doi-asserted-by":"publisher","unstructured":"Zonios DI, Bennett JE (2008) Update on azole antifungals. In: Seminars in respiratory and critical care medicine. Thieme Medical Publishers, New York, pp 198\u2013210. https:\/\/doi.org\/10.1055\/s-2008-1063858","DOI":"10.1055\/s-2008-1063858"},{"issue":"6","key":"9992_CR166","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1040-0486(00)90023-1","volume":"12","author":"A Pardasani","year":"2000","unstructured":"Pardasani A (2000) Oral antifungal agents used in dermatology. Curr Probl Dermatol 12(6):270\u2013275. https:\/\/doi.org\/10.1016\/S1040-0486(00)90023-1","journal-title":"Curr Probl Dermatol"},{"key":"9992_CR167","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0924-8579(00)00258-2","volume":"16","author":"T Vincent","year":"2000","unstructured":"Vincent T (2000) Current and future antifungal therapy: new targets for antifungal therapy. Int J Antimicrob Agents 16:317\u2013321. https:\/\/doi.org\/10.1016\/S0924-8579(00)00258-2","journal-title":"Int J Antimicrob Agents"},{"key":"9992_CR168","first-page":"199","volume-title":"The yeasts: yeast organelles, 4","author":"G Fleet","year":"1991","unstructured":"Fleet G (1991) Cell walls. In: Rose AH, Harrison JS (eds) The yeasts: yeast organelles, 4, 2nd edn. Acad Press, London, pp 199\u2013277","edition":"2"},{"key":"9992_CR169","doi-asserted-by":"publisher","first-page":"e576","DOI":"10.4317\/jced.51798","volume":"6","author":"C Garcia-Cuesta","year":"2014","unstructured":"Garcia-Cuesta C, Sarrion-P\u00e9rez MG, Bag\u00e1n JV (2014) Current treatment of oral candidiasis: a literature review. J Clin Exp Dent 6:e576\u2013e582. https:\/\/doi.org\/10.4317\/jced.51798","journal-title":"J Clin Exp Dent"},{"key":"9992_CR170","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.1074\/jbc.M707821200","volume":"283","author":"YM Te Welscher","year":"2008","unstructured":"Te Welscher YM, Hendrik H, Balagu\u00e9 MM, Souza CM, Riezman H, De Kruijff B, Breukink E (2008) Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane. J Biol Chem 283:6393\u20136401. https:\/\/doi.org\/10.1074\/jbc.M707821200","journal-title":"J Biol Chem"},{"key":"9992_CR171","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.idc.2015.10.012","volume":"30","author":"JE Nett","year":"2016","unstructured":"Nett JE, Andes DR (2016) Antifungal agents: spectrum of activity, pharmacology, and clinical indications. Infect Dis Clin 30:51\u201383. https:\/\/doi.org\/10.1016\/j.idc.2015.10.012","journal-title":"Infect Dis Clin"},{"key":"9992_CR172","doi-asserted-by":"publisher","first-page":"404","DOI":"10.5694\/j.1326-5377.2007.tb01313.x","volume":"187","author":"SC Chen","year":"2007","unstructured":"Chen SC, Sorrell TC (2007) Antifungal agents. Med J Aust 187:404\u2013409. https:\/\/doi.org\/10.5694\/j.1326-5377.2007.tb01313.x","journal-title":"Med J Aust"},{"key":"9992_CR173","first-page":"345","volume":"42","author":"ZK Khan","year":"2000","unstructured":"Khan ZK, Jain P (2000) Antifungal agents and immunomodulators in systemic mycoses. Indian J Chest Dis Allied Sci 42:345\u2013356","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"9992_CR174","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3109\/13693780903390208","volume":"48","author":"M Hata","year":"2010","unstructured":"Hata M, Ishii Y, Watanabe E, Uoto K, Kobayashi S, Yoshida K-I, Otani T, Ando A (2010) Inhibition of ergosterol synthesis by novel antifungal compounds targeting C-14 reductase. Med Mycol 48:613\u2013621. https:\/\/doi.org\/10.3109\/13693780903390208","journal-title":"Med Mycol"},{"key":"9992_CR175","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.3390\/molecules17055713","volume":"17","author":"AA Al-Amiery","year":"2012","unstructured":"Al-Amiery AA, Kadhum AAH, Mohamad AB (2012) Antifungal activities of new coumarins. Molecules 17:5713\u20135723. https:\/\/doi.org\/10.3390\/molecules17055713","journal-title":"Molecules"},{"key":"9992_CR176","first-page":"2495","volume":"4","author":"A Behrami","year":"2012","unstructured":"Behrami A, Krasniqi I (2012) Antibacterial activity of coumarine derivatives synthesized from 8-amino-4,7-dihydroxy-chromen-2-one and comparison with standard drug. J Chem Pharm Res 4:2495\u20132500","journal-title":"J Chem Pharm Res"},{"key":"9992_CR177","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0014-827X(98)00047-0","volume":"53","author":"L Bonsignore","year":"1998","unstructured":"Bonsignore L, Cottiglia F, Elkhaili H, Jehl F, Lavagna SM, Loy G, Manna F, Monteil H, Pompei D, Secci D (1998) Synthesis and antimicrobial activity of coumarin 7-substituted cephalosporins and sulfones. Il Farmaco 53:425\u2013430. https:\/\/doi.org\/10.1016\/S0014-827X(98)00047-0","journal-title":"Il Farmaco"},{"key":"9992_CR178","doi-asserted-by":"crossref","unstructured":"Brahmbhatt D, Kaneria AR, Patel AK, Patel NH (2010) Synthesis and antimicrobial screening of some 3-[4-(3-aryl-1-phenyl-1H-pyrazol-4-yl)-6-aryl-pyridin-2-yl] and 4-methyl-3-phenyl-6-[4-(3-aryl-1-phenyl-1H-pyrazol-4-yl)-6-aryl-pyridin-2-yl] coumarins. CSIR, pp 971\u2013977. http:\/\/hdl.handle.net\/123456789\/9935 . Accessed July 2010","DOI":"10.1002\/chin.201047141"},{"key":"9992_CR179","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1155\/2009\/874389","volume":"6","author":"S Bairagi","year":"2009","unstructured":"Bairagi S, Bhosale A, Deodhar MN (2009) Design, synthesis and evaluation of Schiff\u2019s bases of 4-chloro-3-coumarin aldehyde as antimicrobial agents. J Chem 6:759\u2013762. https:\/\/doi.org\/10.1155\/2009\/874389","journal-title":"J Chem"},{"key":"9992_CR180","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12039-009-0058-z","volume":"121","author":"M Basanagouda","year":"2009","unstructured":"Basanagouda M, Kulkarni MV, Sharma D, Gupta VK, Sandhyarani P, Rasal VP (2009) Synthesis of some new 4-aryloxmethylcoumarins and examination of their antibacterial and antifungal activities. J Chem Sci 121:485\u2013495. https:\/\/doi.org\/10.1007\/s12039-009-0058-z","journal-title":"J Chem Sci"},{"key":"9992_CR181","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/molecules23051222","volume":"23","author":"J Widelski","year":"2018","unstructured":"Widelski J, Luca SV, Skiba A, Chinou I, Marcourt L, Wolfender J-L, Skalicka-Wozniak K (2018) Isolation and antimicrobial activity of coumarin derivatives from fruits of Peucedanum luxurians Tamamsch. Molecules 23:1222. https:\/\/doi.org\/10.3390\/molecules23051222","journal-title":"Molecules"},{"key":"9992_CR182","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s10593-016-1898-3","volume":"52","author":"SY Zhang","year":"2016","unstructured":"Zhang SY, Fu DJ, Sun HH, Yue XX, Liu YC, Zhang YB, Liu HM (2016) Synthesis and bioactivity of novel coumarin derivatives. Chem Heterocycl Compd 52:374\u2013378","journal-title":"Chem Heterocycl Compd"},{"issue":"2","key":"9992_CR183","doi-asserted-by":"crossref","first-page":"146","DOI":"10.7883\/yoken.JJID.2009.146","volume":"62","author":"M Dizbay","year":"2009","unstructured":"Dizbay M et al (2009) Fungemia and cutaneous zygomycosis due to Mucor circinelloides in an intensive care unit patient: case report and review of literature. Jpn J Infect Dis 62(2):146\u2013148","journal-title":"Jpn J Infect Dis"},{"key":"9992_CR184","unstructured":"Kobayashi GS (1996) Disease mechanisms of fungi. In: Baron S (ed) Medical microbiology, 4th edn. Galveston"},{"issue":"12","key":"9992_CR185","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1086\/588300","volume":"46","author":"SW Chapman","year":"2008","unstructured":"Chapman SW, Dismukes WE, Proia LA, Bradsher RW, Pappas PG, Threlkeld MG, Kauffman CA (2008) Clinical practice guidelines for the management of blastomycosis: 2008 Update by the Infectious Diseases Society of America. Clin Infect Dis 46(12):1801\u20131812. https:\/\/doi.org\/10.1086\/588300","journal-title":"Clin Infect Dis"},{"key":"9992_CR186","doi-asserted-by":"publisher","unstructured":"Tavanti A, Naglik JR, Osherov N (2012). Host\u2013fungal interactions: pathogenicity versus immunity. Int J Microbiol Article ID 562480. https:\/\/doi.org\/10.1155\/2012\/562480","DOI":"10.1155\/2012\/562480"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-019-09992-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11030-019-09992-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-019-09992-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T06:26:30Z","timestamp":1695191190000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11030-019-09992-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":186,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["9992"],"URL":"https:\/\/doi.org\/10.1007\/s11030-019-09992-x","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,13]]},"assertion":[{"value":"23 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}